Shareholder plans sale of 1,925 common shares

A shareholder has filed a notice of proposed sales of common stock, indicating an intent to sell 1,925 shares through Fidelity Brokerage Services LLC on or around 02/11/2026 on the NASDAQ.

Rhea-AI Filing Summary

A shareholder has filed a notice of proposed sales of common stock, indicating an intent to sell 1,925 shares through Fidelity Brokerage Services LLC on or around 02/11/2026 on the NASDAQ. The filing lists an aggregate market value of $886,327.75 for these shares and shows 253,718,831 shares of this class outstanding.

The 1,925 shares were acquired on 02/10/2026 through restricted stock vesting from the issuer as compensation. The document also reports that Jonathan Biller sold 347 common shares for $155,803.00 on 12/03/2025 during the past three months.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is disclosed in this Form 144 related to VRTX?

The filing discloses a planned sale of 1,925 common shares. The shares are expected to be sold through Fidelity Brokerage Services LLC on or about February 11, 2026, on NASDAQ, with an aggregate market value stated as $886,327.75 in the document.

How were the 1,925 VRTX shares being sold under Form 144 acquired?

The 1,925 shares were acquired through restricted stock vesting. The document states they were obtained on February 10, 2026, directly from the issuer as compensation, with the same date listed as the payment date for this compensation-related stock award.

What recent prior sales by the same seller are reported for VRTX stock?

The filing reports a prior sale of 347 common shares. It lists Jonathan Biller as the seller of these shares on December 3, 2025, with gross proceeds of $155,803.00, covering all sales by this person in the last three months.

How many VRTX shares of this class are outstanding in the Form 144?

The document lists 253,718,831 shares of the class outstanding. This figure appears in the securities information section alongside the sale details, providing a baseline context for the 1,925-share planned sale described in the filing.

Which broker and exchange are used for the planned VRTX share sale?

The planned sale is through Fidelity Brokerage Services LLC on NASDAQ. The broker’s address is listed as 900 Salem Street, Smithfield, RI 02917, and NASDAQ is named as the securities exchange for executing the transaction.

Who is identified as a recent seller of VRTX common stock in this filing?

Jonathan Biller is identified as a recent seller of common shares. The document shows his address in Boston, Massachusetts, and records his sale of 347 shares on December 3, 2025, including the gross proceeds from that transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/11/2026 - 11:30 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001744749
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Biller Jonathan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1925	886327.75	253718831	02/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Restricted Stock Vesting	Issuer			1925	02/10/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan Biller 50 Northern Avenue Boston MA 02210	Common	12/03/2025	347	155803.00

144: Remarks and Signature

Remarks
Date of Notice	02/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jonathan P. Biller
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)